Rafael Holdings, Inc. amended its previous 8-K filing from March 26, 2025, to include audited financial statements of Cyclo Therapeutics following its merger with the company. The financial details include a balance sheet as of January 31, 2025, and operations for six months ending the same date and for the year ending July 31, 2024.